cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Day One Biopharmaceuticals I
5 own
5 watching
Current Price
$14.96
$-0.79
(-5.02%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,029.27M
52-Week High
52-Week High
17.85000
52-Week Low
52-Week Low
9.67000
Average Volume
Average Volume
1.38M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,029.27M
icon52-Week High17.85000
icon52-Week Low9.67000
iconAverage Volume1.38M
iconDividend Yield--
iconP/E Ratio--
What does the Day One Biopharmaceuticals I do?
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Read More
How much money does Day One Biopharmaceuticals I make?
News & Events about Day One Biopharmaceuticals I.
Globe Newswire
10 months ago
BRISBANE, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced the closing on June 12...
Globe Newswire
11 months ago
FIREFLY-1 clinical abstract selected for oral presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Leadership team strengthened with executive appointments in clinical development and commercialization Pre-New Drug Application (NDA) meeting held April 19, 2023 with U....
Ticker Report
12 months ago
Bank of America lowered shares of Day One Biopharmaceuticals (NASDAQ:DAWN Get Rating) from a buy rating to an underperform rating in a research note published on Tuesday , The Fly reports. DAWN has been the topic of a number of other reports. Piper Sandler raised their price target on shares...
Globe Newswire
12 months ago
New clinical data from registrational FIREFLY-1 study to be featured as an oral presentation Trial-in-progress poster from FIREFLY-2 and healthcare resource use for pediatric low-grade glioma care poster to be presented Company to host conference call and webcast on Sunday, June 4, 2023 at 6:00 PM ...
Globe Newswire
1 year ago
BRISBANE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced an upcoming poster ...
Frequently Asked Questions
Frequently Asked Questions
What is Day One Biopharmaceuticals I share price today?
plus_minus_icon
Can Indians buy Day One Biopharmaceuticals I shares?
plus_minus_icon
How can I buy Day One Biopharmaceuticals I shares from India?
plus_minus_icon
Can Fractional shares of Day One Biopharmaceuticals I be purchased?
plus_minus_icon
What are the documents required to start investing in Day One Biopharmaceuticals I stocks?
plus_minus_icon
What is today’s traded volume of Day One Biopharmaceuticals I?
plus_minus_icon
What is today’s market capitalisation of Day One Biopharmaceuticals I?
plus_minus_icon
What is the 52-Week High and Low Range of Day One Biopharmaceuticals I?
plus_minus_icon
What percentage is Day One Biopharmaceuticals I down from its 52-Week High?
plus_minus_icon
What percentage is Day One Biopharmaceuticals I up from its 52-Week Low?
plus_minus_icon
Current Price
$14.96
$-0.79
(-5.02%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00